Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > How should this be graded in the weekly report card?

<< Previous

Bullboard Posts

Next >>

Post by SPCEO1on Jun 15, 2021 11:17am

162 Views

Post# 33388366

How should this be graded in the weekly report card?

Obviously, the much needed website upgrade is a positive. But no website at all is not a positive. How hard is it to turn an old website off and turn a new one on? It is not that hard at all. So, how is this website outage even happening? It is not a good look that they cannot seem to handle such a fundamentaly easy task. But I am sure they will get it sorted out and we will then be able to see if the new website is a significant upgrade.

<< Previous

Bullboard Posts

Next >>

DRI Healthcare stock drops 28% after executive changes